PR Newswire Clinical TrialsOriginal article
Flagship Pioneering Awarded First-Of-Its-Kind Contract by Department of War to Advance Next-Generation Medical Countermeasure Technologies Against Evolving Biological Threats
PartnershipPositive
AI Analysis
Summary
Flagship Pioneering was awarded a contract worth up to $47 million over five years by the Department of War to advance next-generation medical countermeasure technologies against evolving biological threats, with initial projects including Flagship-founded Apriori.
Outcome Details
Contract awarded for medical countermeasure technologies development
Importance:6/10
Sentiment:
0.60
government contractmedical countermeasuresbiological threatsFlagship PioneeringDepartment of War
Read the original article
Published by PR Newswire Clinical Trials on September 23, 2026 10:30 AM